- United States
- /
- Medical Equipment
- /
- NasdaqGS:QDEL
Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet
With a price-to-earnings (or "P/E") ratio of 5.2x QuidelOrtho Corporation (NASDAQ:QDEL) may be sending very bullish signals at the moment, given that almost half of all companies in the United States have P/E ratios greater than 15x and even P/E's higher than 29x are not unusual. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so limited.
QuidelOrtho could be doing better as it's been growing earnings less than most other companies lately. The P/E is probably low because investors think this lacklustre earnings performance isn't going to get any better. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.
View our latest analysis for QuidelOrtho
Keen to find out how analysts think QuidelOrtho's future stacks up against the industry? In that case, our free report is a great place to start.Does Growth Match The Low P/E?
The only time you'd be truly comfortable seeing a P/E as depressed as QuidelOrtho's is when the company's growth is on track to lag the market decidedly.
If we review the last year of earnings growth, the company posted a worthy increase of 4.6%. Pleasingly, EPS has also lifted 759% in aggregate from three years ago, partly thanks to the last 12 months of growth. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.
Turning to the outlook, the next three years should bring diminished returns, with earnings decreasing 44% each year as estimated by the five analysts watching the company. With the market predicted to deliver 9.7% growth each year, that's a disappointing outcome.
In light of this, it's understandable that QuidelOrtho's P/E would sit below the majority of other companies. However, shrinking earnings are unlikely to lead to a stable P/E over the longer term. Even just maintaining these prices could be difficult to achieve as the weak outlook is weighing down the shares.
The Bottom Line On QuidelOrtho's P/E
Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.
We've established that QuidelOrtho maintains its low P/E on the weakness of its forecast for sliding earnings, as expected. Right now shareholders are accepting the low P/E as they concede future earnings probably won't provide any pleasant surprises. Unless these conditions improve, they will continue to form a barrier for the share price around these levels.
It is also worth noting that we have found 3 warning signs for QuidelOrtho (2 don't sit too well with us!) that you need to take into consideration.
You might be able to find a better investment than QuidelOrtho. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a P/E below 20x (but have proven they can grow earnings).
Valuation is complex, but we're here to simplify it.
Discover if QuidelOrtho might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:QDEL
Undervalued with worrying balance sheet.